Recent Patents on Drug Delivery & Formulation
Title:Anti-Cancer Products from Marine Sponges: Progress and Promise
Volume: 9 Issue: 3
Author(s): Abolfazl Shakeri and Amirhossein Sahebkar
Affiliation:
Export Options
About this article
Cite this article as:
Shakeri Abolfazl and Sahebkar Amirhossein, Anti-Cancer Products from Marine Sponges: Progress and Promise, Recent Patents on Drug Delivery & Formulation 2015; 9 (3) . https://dx.doi.org/10.2174/1872211309666150529131549
DOI https://dx.doi.org/10.2174/1872211309666150529131549 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
30
4
Related Articles
-
Plant Proteinases and Inhibitors: An Overview of Biological Function and Pharmacological Activity
Current Protein & Peptide Science Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) A Sensitive Determination of Ammonia and Nitrite in Exhaled Breath Condensate of Healthy Humans by Using Berthelot Reaction
Current Pharmaceutical Analysis Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Clinical Application of Ghrelin
Current Pharmaceutical Design Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science The Role of ABCG2 and ABCB6 in Porphyrin Metabolism and Cell Survival
Current Pharmaceutical Biotechnology Poxvirus Cancer Therapy
Recent Patents on Anti-Infective Drug Discovery Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review
Current Neuropharmacology Repurposing Drugs for Cancer Prevention
Current Topics in Medicinal Chemistry Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design Diverse Roles of GADD45α in Stress Signaling
Current Protein & Peptide Science 3,6-dichloro-1,2,4,5-Tetrazine Assayed at High Doses in the Metastatic Breast Cancer Cell Line MDA-MB-231 Reduces Cell Numbers and Induces Apoptosis
Current Bioactive Compounds Drug Resistance in Renal Tumors of Childhood
Current Pharmaceutical Biotechnology Recent Patents of Gene Sequences Relative to the Phosphatidylinositol 3-kinase / Akt Pathway and their Relevance to Drug Discovery
Recent Patents on DNA & Gene Sequences Emerging Technologies, Recent Developments, and Novel Applications for Drug Metabolite Identification
Current Drug Metabolism Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Current Cancer Therapy Reviews Targeted Drug Delivery for Breast Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Current Cancer Drug Targets Muramyl Dipeptide and its Derivatives: Peptide Adjuvant in Immunological Disorders and Cancer Therapy
Current Bioactive Compounds